The 10 MW core of MURR contributes to the global supply of radioisotopes for medical radiopharmaceuticals and research. (Photo: MURR)
The University of Missouri Research Reactor (MURR) is the latest member of Nuclear Medicine Europe, an industry association for the radiopharmaceutical and molecular imaging industry in Europe, the University of Missouri announced July 17.
A reactor operator at MURR works with a sample can from the reactor pool. (Photo: University of Missouri)
On April 10, the University of Missouri (MU) took its first formal step toward building NextGen MURR when school officials issued the request for qualifications for the project. The RFQ is a solicitation for interested companies to offer the design, engineering, licensing, environmental, and developmental services that are needed for NextGen MURR, planned to be larger and more capable than the school’s existing University of Missouri Research Reactor (MURR)—which itself has been the most powerful research reactor and most intense neutron source on any U.S. campus since it began operating in 1966.
